NATCOPHARMNSENatco Pharma Limited· PharmaceuticalsLowNeutral
Announced Fri, 6 Mar · 10:23 IST

Natco Pharma Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NATCOPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Natco Pharma has informed the stock exchanges that its officials will participate in the Investec Promoter and Founder Conference 2026 scheduled for 9th March 2026 in Mumbai, between 9:00 AM and 5:00 PM. The meeting will be held in-person and in a group format. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be discussed during the interaction. The disclosure is made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, 2015.

Likely market impact

This is a routine investor engagement disclosure with no material business or financial impact. Shareholders should not expect any new information or price-moving announcements from this meeting, as the company has confirmed no UPSI will be shared.